Why This Matters

1. Referral timing is a limb- and life-saving decision. Chronic wounds—especially diabetic foot ulcers (DFUs)—carry significant amputation and mortality risk. With DFUs preceding approximately 85% of diabetes-related amputations and 5-year mortality after major amputation reaching up to 70%, delayed escalation is not a minor delay—it can be catastrophic.

2. Ischemia and infection are time-sensitive red flags that require early escalation. Peripheral arterial disease (PAD) and infection are the two most critical drivers of poor outcomes, with underdiagnosis being common, and symptom presentations variable, delayed referral and/or intervention can significantly increase mortality and morbidity risk.

3. Early, multidisciplinary referral improves outcomes and reduces system costs. Beyond clinical outcomes, delayed referral increases hospitalization, system costs, and institutional quality risk under value-based reimbursement models.

The High Stakes of Referral Timing in Wound Care

For clinicians early in their wound care careers, or even for more seasoned practitioners, one of the most challenging questions is not how to treat a wound—but when to refer it.

Chronic wounds, particularly diabetic foot ulcers (DFUs), arterial ulcers, and infected lower extremity wounds, carry substantial morbidity and mortality. An estimated 19% to 34% of individuals with diabetes will develop a DFU during their lifetime.¹ DFUs precede approximately 85% of diabetes-related lower extremity amputations.² In the United States alone, diabetes remains the leading cause of nontraumatic lower limb amputation.³

Importantly, amputation is not a benign endpoint. Five-year mortality after major lower extremity amputation ranges from 40% to 70%, exceeding the mortality of many common cancers.⁴ Delayed recognition of ischemia, uncontrolled infection, or structural instability significantly increases this risk.

For wound professionals, referral timing is not a minor workflow issue—it is a limb- and life-determining decision.
 

Peripheral Arterial Disease: Common, Underdiagnosed, and Dangerous

Peripheral arterial disease (PAD) is one of the most critical drivers of poor wound healing and amputation risk. Globally, more than 230 million people are estimated to be living with PAD.⁵ In patients with diabetes and foot ulcers, PAD is present in up to 50% of cases.⁶

PAD reduces perfusion, impairs oxygen delivery, and dramatically decreases the likelihood of wound healing. The International Working Group on the Diabetic Foot (IWGDF) emphasizes that ischemia is a major predictor of nonhealing and amputation.6 Patients with combined neuropathy and ischemia have significantly worse outcomes than those with neuropathy alone.
Yet PAD is frequently underrecognized. Classic symptoms such as claudication may be absent, particularly in patients with diabetic neuropathy.⁷ Reliance on symptoms alone can delay referral for vascular assessment.

Objective vascular evaluation—including pulse assessment and noninvasive testing when indicated—is essential. Studies demonstrate that delayed revascularization in patients with ischemic DFUs is associated with higher rates of major amputation.⁸ Early identification and referral to vascular specialists improve limb salvage rates.⁸
For entry-level clinicians, understanding that “not healing as expected” may represent underlying ischemia—and not simply inadequate local wound care—is a foundational insight.

Infection and Surgical Escalation

Infection is another time-sensitive driver of referral. Approximately 20% to 60% of DFUs become infected during their course.⁹ Diabetic foot infections (DFIs) are the most common diabetes-related cause of hospitalization and precede most amputations.⁹
The presence of deep infection, abscess, necrotizing infection, or suspected osteomyelitis dramatically increases amputation risk.^9,10 In a large cohort study, patients hospitalized with DFIs had significantly higher rates of both minor and major amputation compared with those without infection.¹⁰ The Infectious Diseases Society of America (IDSA) and IWGDF guidelines emphasize that moderate to severe DFIs frequently require surgical evaluation in addition to antimicrobial therapy.⁹

For clinicians early in practice, it can be difficult to distinguish between “routine” wound deterioration and a surgical red flag. However, delays in escalating care for limb-threatening infection can allow rapid progression to sepsis, systemic compromise, and amputation.

The Consequences of Delayed Referral

Multiple studies demonstrate that fragmented care and delayed specialist involvement correlate with worse outcomes.
In a population-based analysis, regions with greater access to vascular specialists and revascularization procedures had significantly lower major amputation rates.¹¹ Conversely, limited access and delayed referral were associated with higher amputation incidence.¹¹

Time to revascularization matters. Data suggest that early revascularization in patients with ischemic DFUs improves wound healing and reduces major amputation compared with delayed or absent intervention.⁸

Similarly, multidisciplinary diabetic foot programs—including coordinated vascular, surgical, podiatric, and wound care services—have been associated with reductions in major amputation rates of 30% to 50%.¹² These improvements are not due to a single intervention, but to earlier identification of high-risk patients and streamlined referral pathways.
For early-career clinicians, this reinforces a powerful principle: referral is not a sign of failure. It is a risk-mitigation strategy supported by outcomes data.

The Health System and Reimbursement Impact

Chronic wounds and related amputations generate substantial financial burden. Medicare expenditures for diabetic foot ulcers alone have been estimated in the billions annually.¹³ Hospitalizations for infection, revascularization procedures, and amputation significantly increase per-patient costs.

From a regulatory perspective, avoidable complications influence quality metrics, readmission rates, and publicly reported outcomes. Increasingly, payers and policymakers are focusing on limb preservation as a quality benchmark.
For wound care professionals, delayed referral does not only affect patient outcomes—it can influence institutional performance, risk adjustment, and reimbursement under value-based models.

Clear communication with surgical and vascular colleagues, accurate documentation of clinical concern, and structured referral pathways are therefore not administrative details—they are system-level quality drivers.

Why Entry-Level Clinicians Need Clarity on Referral Timing

Early in a wound care career, clinicians often focus heavily on local wound management: dressings, debridement, moisture balance, and infection control. While essential, these skills represent only part of limb preservation. Knowing when a wound exceeds the scope of conservative management is equally critical. Understanding clinical “red flags” for ischemia, recognizing patterns suggestive of deep infection, and appreciating when structural or surgical evaluation is warranted can change the trajectory of a patient’s limb—and life.

As diabetes prevalence rises and the population ages, the incidence of chronic lower extremity wounds will continue to grow.³ Clinicians are on the front lines of identifying high-risk patients. Referral decisions—particularly for vascular assessment and surgical consultation—represent pivotal moments in care. Delayed escalation can contribute to preventable amputations, higher mortality, and escalating system costs. Timely referral, by contrast, is associated with improved limb salvage and survival.^8,12
“When to Refer” is one of the most consequential—and potentially anxiety-provoking—decisions in wound care practice. By grounding referral timing in epidemiology, risk data, and interdisciplinary evidence, clinicians gain clarity and confidence in protecting their patients’ limbs.

In wound care, knowing when to escalate may be just as important as knowing how to treat.

References
1.    Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367-2375. doi:10.1056/NEJMra1615439
2.    Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Diabetes Care. 1990;13(5):513-521. doi:10.2337/diacare.13.5.513
3.    Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2022. US Department of Health and Human Services; 2022.
4.    Hoffstad O, Mitra N, Walsh J, et al. Diabetes, lower-extremity amputation, and death. Diabetes Care. 2015;38(10):1852-1857. doi:10.2337/dc15-0536
5.    Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7(8):e1020-e1030. doi:10.1016/S2214-109X(19)30255-4
6.    Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. IWGDF guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with a foot ulcer and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1):e3276. doi:10.1002/dmrr.3276
7.    Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509-1526. doi:10.1161/CIRCRESAHA.116.303849
8.    Elgzyri T, Larsson J, Thörne J, Eriksson KF, Apelqvist J. Early revascularization after admission to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes. Eur J Vasc Endovasc Surg. 2014;48(4):440-446. doi:10.1016/j.ejvs.2014.06.041
9.    Lipsky BA, Senneville E, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1):e3280. doi:10.1002/dmrr.3280
10.    Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJM. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288-1293. doi:10.2337/dc05-2425
11.    Goodney PP, Holman K, Henke PK, et al. Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg. 2013;57(6):1471-1480.e3. doi:10.1016/j.jvs.2012.12.037
12.    Krishnan S, Nash F, Baker N, Fowler D, Rayman G. Reduction in diabetic amputations over 11 years in a defined U.K. population. Diabetes Care. 2008;31(1):99-101. doi:10.2337/dc07-1178
13.    Rice JB, Desai U, Cummings AKG, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care. 2014;37(3):651-658. doi:10.2337/dc13-2176